Azzam O

Crowe A

Sajiv, Cherian

Pawar B

2015-10-05

A 33-year-old Caucasian man with end-stage renal disease secondary to biopsy-proven IgA nephropathy, managed with continuous ambulatory peritoneal dialysis (PD), presented with PD-related peritonitis, the causal organism being a non-branching Gram-positive bacillus, Rhodococcus equi. Initial empirical Gram positive and negative coverage with cefazolin and ceftazidime was unsuccessful, but following isolation of the organism, and conversion to intraperitoneal vancomycin and oral ciprofloxacin, the peritonitis episode resolved. At day 10, vancomycin was switched to azithromycin for a total of 6 weeks of antimicrobial therapy. The PD catheter was preserved, and the patient remained peritonitis-free at 6 months of follow-up.

BMJ Case Rep . 2015 Oct 5:2015:bcr2014207753. doi: 10.1136/bcr-2014-207753.

https://pubmed.ncbi.nlm.nih.gov/26438670/?otool=iaurydwlib

https://hdl.handle.net/10137/5431

Actinomycetales Infections

Adult

Anti-Infective Agents

Australia

Azithromycin

Ciprofloxacin

Drug Therapy, Combination

Follow-Up Studies

Humans

Kidney Failure, Chronic

Male

Peritoneal Dialysis, Continuous Ambulatory

Peritonitis

Rhodococcus equi

Treatment Outcome

Vancomycin

Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Australia.

Journal Article

Publication